Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

NYSE:BXC - New York Stock Exchange, Inc. - US09624H2085 - Common Stock - Currency: USD

82.53  -7.71 (-8.54%)

After market: 83.04 +0.51 (+0.62%)

Fundamental Rating

5

BXC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 48 industry peers in the Trading Companies & Distributors industry. BXC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BXC has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BXC was profitable.
In the past year BXC had a positive cash flow from operations.
BXC had positive earnings in each of the past 5 years.
In the past 5 years BXC always reported a positive cash flow from operatings.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of BXC (3.37%) is comparable to the rest of the industry.
BXC's Return On Equity of 8.22% is on the low side compared to the rest of the industry. BXC is outperformed by 65.96% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.37%, BXC is doing worse than 72.34% of the companies in the same industry.
BXC had an Average Return On Invested Capital over the past 3 years of 11.49%. This is in line with the industry average of 9.88%.
The last Return On Invested Capital (4.37%) for BXC is well below the 3 year average (11.49%), which needs to be investigated, but indicates that BXC had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.37%
ROE 8.22%
ROIC 4.37%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

Looking at the Profit Margin, with a value of 1.80%, BXC is doing worse than 70.21% of the companies in the same industry.
BXC's Profit Margin has declined in the last couple of years.
BXC has a Operating Margin of 2.96%. This is in the lower half of the industry: BXC underperforms 76.60% of its industry peers.
In the last couple of years the Operating Margin of BXC has grown nicely.
BXC has a worse Gross Margin (16.57%) than 91.49% of its industry peers.
BXC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.96%
PM (TTM) 1.8%
GM 16.57%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BXC is creating some value.
BXC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BXC has been reduced compared to 5 years ago.
BXC has a better debt/assets ratio than last year.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BXC has an Altman-Z score of 3.65. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
BXC has a Altman-Z score of 3.65. This is in the better half of the industry: BXC outperforms 72.34% of its industry peers.
BXC has a debt to FCF ratio of 13.04. This is a negative value and a sign of low solvency as BXC would need 13.04 years to pay back of all of its debts.
BXC's Debt to FCF ratio of 13.04 is in line compared to the rest of the industry. BXC outperforms 55.32% of its industry peers.
BXC has a Debt/Equity ratio of 0.89. This is a neutral value indicating BXC is somewhat dependend on debt financing.
BXC has a Debt to Equity ratio (0.89) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 13.04
Altman-Z 3.65
ROIC/WACC0.43
WACC10.25%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BXC has a Current Ratio of 4.85. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
BXC's Current ratio of 4.85 is amongst the best of the industry. BXC outperforms 97.87% of its industry peers.
A Quick Ratio of 3.33 indicates that BXC has no problem at all paying its short term obligations.
BXC's Quick ratio of 3.33 is amongst the best of the industry. BXC outperforms 95.74% of its industry peers.
Industry RankSector Rank
Current Ratio 4.85
Quick Ratio 3.33
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -43.84% in the last year.
BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.26% yearly.
BXC shows a decrease in Revenue. In the last year, the revenue decreased by -5.86%.
The Revenue has been growing slightly by 2.28% on average over the past years.
EPS 1Y (TTM)-43.84%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-79.25%
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-0.27%

3.2 Future

BXC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.35% yearly.
Based on estimates for the next years, BXC will show a small growth in Revenue. The Revenue will grow by 3.98% on average per year.
EPS Next Y-1.61%
EPS Next 2Y7.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.41%
Revenue Next 2Y3.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.94, BXC is valued correctly.
Based on the Price/Earnings ratio, BXC is valued a bit cheaper than 76.60% of the companies in the same industry.
BXC is valuated cheaply when we compare the Price/Earnings ratio to 29.62, which is the current average of the S&P500 Index.
BXC is valuated correctly with a Price/Forward Earnings ratio of 13.15.
BXC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BXC is cheaper than 74.47% of the companies in the same industry.
BXC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.94
Fwd PE 13.15
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

85.11% of the companies in the same industry are more expensive than BXC, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BXC is valued cheaper than 80.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.35
EV/EBITDA 6.15
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.35%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BXC!.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (2/21/2025, 8:04:45 PM)

After market: 83.04 +0.51 (+0.62%)

82.53

-7.71 (-8.54%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-18 2025-02-18/amc
Earnings (Next)04-28 2025-04-28/amc
Inst Owners93.76%
Inst Owner Change-90.57%
Ins Owners2.01%
Ins Owner Change0.01%
Market Cap691.60M
Analysts80
Price Target138.21 (67.47%)
Short Float %2%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.86%
Min EPS beat(2)16.15%
Max EPS beat(2)61.56%
EPS beat(4)3
Avg EPS beat(4)32.5%
Min EPS beat(4)-4.68%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)24.92%
EPS beat(12)9
Avg EPS beat(12)21.31%
EPS beat(16)13
Avg EPS beat(16)44.25%
Revenue beat(2)1
Avg Revenue beat(2)-1.05%
Min Revenue beat(2)-2.52%
Max Revenue beat(2)0.42%
Revenue beat(4)2
Avg Revenue beat(4)-0.37%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)2.48%
Revenue beat(8)2
Avg Revenue beat(8)-3.84%
Revenue beat(12)4
Avg Revenue beat(12)-1.67%
Revenue beat(16)8
Avg Revenue beat(16)3.08%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-10.66%
EPS NQ rev (3m)-48.96%
EPS NY rev (1m)-1.39%
EPS NY rev (3m)-1.39%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)-5.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 12.94
Fwd PE 13.15
P/S 0.23
P/FCF 15.35
P/OCF 8.12
P/B 1.07
P/tB 1.23
EV/EBITDA 6.15
EPS(TTM)6.38
EY7.73%
EPS(NY)6.28
Fwd EY7.61%
FCF(TTM)5.38
FCFY6.52%
OCF(TTM)10.16
OCFY12.32%
SpS352.33
BVpS77.14
TBVpS67.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.37%
ROE 8.22%
ROCE 6.5%
ROIC 4.37%
ROICexc 7%
ROICexgc 7.76%
OM 2.96%
PM (TTM) 1.8%
GM 16.57%
FCFM 1.53%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.08%
ROICexcg growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score6
Asset Turnover1.87
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 13.04
Debt/EBITDA 4.57
Cap/Depr 104.21%
Cap/Sales 1.36%
Interest Coverage 1.94
Cash Conversion 67.72%
Profit Quality 84.85%
Current Ratio 4.85
Quick Ratio 3.33
Altman-Z 3.65
F-Score6
WACC10.25%
ROIC/WACC0.43
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-43.84%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-79.25%
EPS Next Y-1.61%
EPS Next 2Y7.35%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.86%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-0.27%
Revenue Next Year4.41%
Revenue Next 2Y3.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.96%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year41.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.83%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-72.19%
OCF growth 3Y-16.25%
OCF growth 5YN/A